<?xml version='1.0' encoding='utf-8'?>
<document id="11103251"><sentence text="[The strategy of combination phase I/II study]." /><sentence text="Combination chemotherapy plays an important role in anticancer chemotherapy" /><sentence text=" Many new anticancer drugs, including target-based drugs, have been introduced clinically" /><sentence text=" The opportunity to evaluate combination chemotherapy including new drugs has increased recently" /><sentence text=" Combination phase I/II studies must be designed scientifically and ethically in order to evaluate the efficacy and safety of combination chemotherapy including new drugs" /><sentence text=" It is important to choose appropriate drugs and to determine an effective method of administration, because drug-drug interaction can be a problem in combination chemotherapy" /><sentence text=" It is important to clarify the causes of drug-drug interactions through pharmacokinetics analysis because these interactions influence toxicity and efficacy" /><sentence text=" To conduct high quality clinical trials, we need to improve the infrastructure of such trials" /><sentence text="" /></document>